Hualan Biological Bacterin Inc.
SZSE:301207.SZ
27.9 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2025 Q1 | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 24.283 | 170.449 | 921.834 | -0.585 | 34.223 | 688.169 | 1,568.664 | 4.842 | 144.762 | 265.771 | 499.312 | 1,045.979 | 14.579 | 436.98 | 1,381.929 | -0.083 | 10.989 | 1,318.322 | 1,111.735 | -1.315 | -2.414 |
| Cost of Revenue
| 3.401 | 31.179 | 172.649 | 40.428 | 3.405 | 99.216 | 200.604 | -1.209 | -0.32 | 180.582 | 66.037 | 122.336 | 0.235 | 57.52 | 162.282 | 0.751 | 9.988 | 132.283 | 123.66 | 6.325 | 6.325 |
| Gross Profit
| 20.882 | 139.271 | 749.185 | -41.013 | 30.818 | 588.953 | 1,368.06 | 6.051 | 145.082 | 85.188 | 433.276 | 923.643 | 14.344 | 379.46 | 1,219.647 | -0.834 | 1.001 | 1,186.04 | 988.075 | -7.64 | -8.739 |
| Gross Profit Ratio
| 0.86 | 0.817 | 0.813 | 70.114 | 0.9 | 0.856 | 0.872 | 1.25 | 1.002 | 0.321 | 0.868 | 0.883 | 0.984 | 0.868 | 0.883 | 10.005 | 0.091 | 0.9 | 0.889 | 5.811 | 3.62 |
| Reseach & Development Expenses
| 22.116 | 82.13 | 33.674 | 17.933 | 19.023 | 9.961 | 20.125 | 22.375 | 28.995 | 24.54 | 27.356 | 47.436 | 35.308 | 35.423 | 29.388 | 47.928 | 26.507 | 50.552 | 24.915 | 17.735 | 17.735 |
| General & Administrative Expenses
| 7.948 | -24.744 | 49.157 | -6.174 | 12.652 | -48.987 | 56.027 | -12.726 | 17.175 | 30.189 | 62.026 | -1.427 | 4.933 | 4.912 | 27.755 | 19.541 | 16.583 | -105.427 | 17.916 | 6.875 | 6.875 |
| Selling & Marketing Expenses
| 14.617 | 81.127 | 396.276 | 1.748 | 20.422 | 239.599 | 668.597 | -2.864 | 43.66 | 43.913 | 146.71 | 491.151 | -1.141 | 103.797 | 469.764 | 1.61 | 7.797 | 461.152 | 399.953 | 2.076 | 2.076 |
| SG&A
| 22.565 | 56.383 | 445.433 | -11.328 | 33.074 | 245.343 | 724.624 | -15.589 | 60.835 | 65.92 | 208.736 | 489.725 | 3.792 | 108.709 | 497.52 | 2.935 | -7.032 | 355.724 | 417.869 | 3.692 | 3.692 |
| Other Expenses
| -60.267 | 91.773 | -11.213 | 0.762 | -0.184 | -94.919 | -0.849 | -1.79 | 0.058 | 0 | -0.763 | -0.06 | -0.135 | -0.605 | 3.286 | -36.683 | -21.436 | 1.78 | -0.041 | -6.038 | -25.855 |
| Operating Expenses
| -15.587 | 230.286 | 467.894 | 6.606 | 50.155 | 350.223 | 721.321 | 35.478 | 87.425 | 87.938 | 224.746 | 550.235 | 39.444 | 149.152 | 520.681 | -36.683 | -21.436 | 518.385 | 436.991 | -6.038 | -25.855 |
| Operating Income
| 36.468 | -91.015 | 281.291 | -47.619 | 43.493 | 238.73 | 611.327 | 20.278 | 105.903 | -15.791 | 239.144 | 344.381 | -7.162 | 103.882 | 650.307 | -36.767 | -10.447 | 597.661 | 512.051 | -7.352 | -28.269 |
| Operating Income Ratio
| 1.502 | -0.534 | 0.305 | 81.406 | 1.271 | 0.347 | 0.39 | 4.188 | 0.732 | -0.059 | 0.479 | 0.329 | -0.491 | 0.238 | 0.471 | 441.131 | -0.951 | 0.453 | 0.461 | 5.593 | 11.71 |
| Total Other Income Expenses Net
| -1.131 | -0.34 | -0.548 | 29.468 | 28.733 | 33.173 | -0.849 | 28.978 | 27.293 | 29.865 | 21.155 | 31.431 | 2.938 | 14.647 | -0.169 | -0.365 | -0.088 | 46.95 | -0.041 | -0.104 | 0.273 |
| Income Before Tax
| 35.338 | -91.355 | 280.743 | -18.15 | 43.308 | 271.953 | 610.478 | 18.488 | 105.961 | 14.074 | 238.381 | 344.321 | -7.297 | 103.277 | 650.138 | -37.132 | -10.534 | 597.497 | 512.01 | -7.456 | -27.996 |
| Income Before Tax Ratio
| 1.455 | -0.536 | 0.305 | 31.029 | 1.265 | 0.395 | 0.389 | 3.819 | 0.732 | 0.053 | 0.477 | 0.329 | -0.501 | 0.236 | 0.47 | 445.51 | -0.959 | 0.453 | 0.461 | 5.672 | 11.597 |
| Income Tax Expense
| 2.561 | -29.511 | 38.658 | -4.835 | 4.719 | 41.7 | 88.983 | 4.237 | 11.993 | 0.853 | 31.859 | 45.285 | -6.447 | 10.474 | 92.989 | -12.276 | -6.41 | 84.361 | 73.857 | -3.206 | -5.868 |
| Net Income
| 32.777 | -61.844 | 242.085 | -13.315 | 38.589 | 230.254 | 521.495 | 14.252 | 93.968 | 14.927 | 206.522 | 299.036 | -0.85 | 92.803 | 557.149 | -24.856 | -4.124 | 513.136 | 438.153 | -4.25 | -22.129 |
| Net Income Ratio
| 1.35 | -0.363 | 0.263 | 22.763 | 1.128 | 0.335 | 0.332 | 2.944 | 0.649 | 0.056 | 0.414 | 0.286 | -0.058 | 0.212 | 0.403 | 298.226 | -0.375 | 0.389 | 0.394 | 3.233 | 9.166 |
| EPS
| 0.055 | -0.1 | 0.4 | -0.022 | 0.064 | 0.38 | 0.87 | 0.024 | 0.16 | 0.025 | 0.34 | 0.5 | -0.002 | 0.15 | 0.93 | -0.046 | -0.008 | 0.86 | 0.88 | -0.008 | -0.041 |
| EPS Diluted
| 0.055 | -0.1 | 0.4 | -0.022 | 0.064 | 0.38 | 0.87 | 0.024 | 0.16 | 0.025 | 0.34 | 0.5 | -0.002 | 0.15 | 0.93 | -0.046 | -0.008 | 0.86 | 0.88 | -0.008 | -0.041 |
| EBITDA
| 36.654 | -89.655 | 282.276 | -12.516 | 79.744 | 309.575 | 611.895 | 20.138 | 143.785 | 17.815 | 276.521 | 382.806 | 30.676 | 130.86 | 671.347 | -50.652 | 0.783 | 611.451 | 519.983 | -31.585 | -13.437 |
| EBITDA Ratio
| 1.509 | -0.526 | 0.306 | 21.397 | 2.33 | 0.45 | 0.39 | 4.159 | 0.993 | 0.067 | 0.554 | 0.366 | 2.104 | 0.299 | 0.486 | 607.725 | 0.071 | 0.464 | 0.468 | 24.025 | 5.566 |